Health knowledge and news provided by doctors.

Beaumont Can Test For Heart-Attack Prone Plaques

Armen Hareyan's picture

Heart doctors at Beaumont Hospital, Royal Oak are first in the world with a laser imaging device that identifies the makeup of plaque deposits on artery walls.

As these plaque deposits accumulate, they reduce blood flow to the heart, possibly causing intermittent chest pain called angina, and increasing the likelihood of a heart attack. This happens if one of the deposits is filled with fat and ruptures, cutting off blood and oxygen to the heart. Standard testing using an angiogram identifies narrowings but cannot identify fatty plaques.

"If doctors can identify these fatty plaques, we can recommend better treatment options to patients," says Simon Dixon, M.D., director of the cardiac catheterization laboratories and co-director of cardiac research at Beaumont, Royal Oak. "This information tells us immediately what length of stent (tiny mesh "scaffold" to hold an artery open) to use and where to place it in patients with severe narrowings. Based on further research, this novel device may help determine which type of stent - bare metal or drug-eluting - is best for the patient."

Follow eMaxHealth on YouTube, Twitter and Facebook.
Please, click to subscribe to our Youtube Channel to be notified about upcoming health and food tips.

The device may also hold promise in identifying "vulnerable" plaques that may lead to heart attacks, potentially enabling doctors to prevent them with stents, Dixon says.

Dr. Dixon and colleague Jim Goldstein, M.D., detected a fatty plaque causing a severe narrowing in one of the main arteries of the first patient evaluated with the device after U.S. Food and Drug Administration approval. The patient, a 70-year-old man from Garden City, was treated on May 8. The doctors knew a stent would be the best way to go based on the patient's angiogram, but decided to use a longer stent than the one they chose initially, based on information from the new device.

The U.S. Food and Drug Administration approved the device, the LipiScanTM Coronary Imaging System, in late April. It is a catheter-based system that uses laser light to detect how much fat and other substances are in the deposits. The device is made by InfraReDx Inc. of Burlington, Mass.

The laser light system is not the first detection tool for fatty plaques studied at Beaumont. Cardiologists in the March 25 issue of JACC Cardiovascular Imaging published a first-of-its-kind study showing that unstable coronary plaques can be identified before a heart attack occurs using noninvasive computed tomographic angiography.

Coronary heart disease, which causes heart attacks and chest pain, is the single leading cause of death in America, according to the Web site for the American Heart Association. It accounts for one of every five deaths in America.